Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer

PURPOSE: Valid determination of HER2 status is a prerequisite to establish an adequate treatment strategy for breast cancer patients, regardless of the disease stage. The goal of this study was to examine the feasibility of the newly developed silver-enhanced in situ hybridization (SISH) technique a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Park, Kyeongmee, Han, Sehwan, Kim, Jung-Yeon, Kim, Hyun-Jung, Kwon, Ji Eun, Gwak, Geumhee
Format: Artigo
Idioma:Inglês
Publicat: Korean Breast Cancer Society 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3268923/
https://ncbi.nlm.nih.gov/pubmed/22323913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2011.14.4.276
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars